Read More Pharma Industry News Novartis’ Kisqali plus endocrine therapy shows significant PFS benefits in advanced breast cancer trials Swiss pharmaceutical giant Novartis has announced that its breast cancer drug, Kisqali (ribociclib), when used in combination with… bypharmanewsdailyDecember 9, 2018
